News / 

Lawmakers weigh costs of screening for rare, fatal disease


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

FRANKFORT, Ky. (AP) — Kentucky lawmakers are weighing the benefits of testing newborns for a rare, usually fatal disease versus the projected $250,000 annual cost to detect it.

The House is considering a bill that would require the state to test all newborns for Krabbe disease, a genetic disorder that is usually fatal by age 2. Some infants tested at birth have lived productive lives after receiving a stem cell transplant from cord blood.

The bill passed the Republican-controlled state Senate 35-0. Then the Legislative Research Commission estimated it would cost the Department of Public Health about $500,000 every two years to test for the disease. Now some House lawmakers are concerned about the cost.

Krabbe disease occurs in about 1 out of every 100,000 people. Kentucky averages 60,000 births each year.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent News stories

ADAM BEAM

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast